Records
Browse every document routed through Assort Design.
Route Filters
Alcohol-related Liver Disease - Nordic Bioscience Skip to content Webinars and blog Why Biomarkers? Contact Menu Biomarker Solutions Biomarker Solutions Learn how Nordic ProteinFingerPrint™ biomarkers
One-line summary: Nordic Bioscience provides extracellular matrix remodeling biomarkers for diagnosing, monitoring, and prognosticating alcohol-related liver disease to enhance clinical decision-making and drug development.
Citations: 2 · Risk: 1 High / 1 Medium / 0 Low
Title: Iterative Lab Development of a Solid-State Battery Electrolyte Through Hypothesis-Driven Experiments A materials research group is working on a next-generation solid-state battery electrolyt
One-line summary: A hypothesis-driven lab development program is advancing understanding of solid-state battery electrolytes by systematically varying formulation and processing parameters to elucidate ion transport and interfacial stability mechanisms.
Citations: 3 · Risk: 0 High / 0 Medium / 0 Low
Nwd1 gene linked to liver dysfunction in metabolic disease Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health
One-line summary: Nwd1 gene deficiency disrupts ER calcium homeostasis via SERCA2 inhibition, inducing MASH-like liver dysfunction and suggesting Nwd1 as a novel therapeutic target.
Citations: 4 · Risk: 1 High / 0 Medium / 0 Low
Study calls for new gold standard in research to treat non-alcoholic steatohepatitis Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About F
One-line summary: The study advocates a new human-relevant gold standard using in vitro and omics techniques to better understand and treat non-alcoholic steatohepatitis (NASH), addressing limitations of current animal models.
Citations: 2 · Risk: 1 High / 1 Medium / 0 Low
Researchers uncover new genetic link to non-alcoholic steatohepatitis Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food
One-line summary: A point mutation in the tyrosinase gene increases susceptibility to diet-induced NASH in albino mice via altered cholesterol uptake in the intestine, suggesting genetic influence on NASH pathophysiology.
Citations: 2 · Risk: 1 High / 0 Medium / 0 Low
Researchers find possible genetic basis and mouse model for nonalcoholic steatohepatitis Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home Abo
One-line summary: Researchers identified the SRSF1 gene as a protective factor against DNA damage in liver cells, and its absence in a novel mouse model replicates all hallmarks of nonalcoholic steatohepatitis (NASH), proposing a new genetic basis for the disease.
Citations: 3 · Risk: 1 High / 0 Medium / 0 Low
Researchers identify a previously unknown cellular barrier in the brain VIB and Ghent University researchers have identified and characterized a previously unknown cellular barrier in the brain, which
One-line summary: Researchers discovered and characterized a novel dynamic cellular barrier at the base of the choroid plexus that segregates brain, CSF, and blood compartments and is vulnerable to systemic inflammation.
Citations: 1 · Risk: 0 High / 0 Medium / 1 Low
Biological safety cabinets vs. laminar flow cabinets Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-Z D
One-line summary: Biological Safety Cabinets (BSCs) and Laminar Flow Cabinets (LFCs) differ fundamentally in airflow design and protection scope, with BSCs safeguarding personnel, product, and environment in biocontainment, while LFCs only protect product sterility without personnel or environmental safety.
Citations: 2 · Risk: 2 High / 1 Medium / 0 Low
Madrigal Expands its MASH Pipeline with Exclusive Global Accessibility: Skip TopNav Consumer Products and Services News Automobiles and Parts News Food & Beverage News Home Goods & Construction News L
One-line summary: Madrigal Pharmaceuticals broadens its MASH treatment pipeline by securing exclusive global rights to six preclinical siRNA programs, complementing its foundational drug Rezdiffra and aiming for genetically targeted MASH therapies.
Citations: 5 · Risk: 1 High / 0 Medium / 0 Low
Madrigal Expands its MASH Pipeline with Exclusive Global Licensing Agreement for Six Preclinical siRNA Programs February 11, 2026 PDF Version Company advances its leadership in MASH with an expande
One-line summary: Madrigal expands its MASH pipeline by licensing six preclinical siRNA programs targeting genetic drivers for better precision therapies alongside its foundational drug Rezdiffra.
Citations: 5 · Risk: 1 High / 0 Medium / 0 Low